Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'T-PA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 498 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Nakazawa, I; Nakajima, T; Ishigami, T; Umemura, S; Emi, M
      Linkage disequilibrium and haplotype analysis among eight novel single-nucleotide polymorphisms in the human tissue-type plasminogen activator (t-PA)gene

      JOURNAL OF HUMAN GENETICS
    2. Toss, H; Wallentin, L; Siegbahn, A
      Effects of low-molecular-weight heparin treatment on fibrinolytic markers in unstable coronary artery disease

      FIBRINOLYSIS & PROTEOLYSIS
    3. Vermeulen, LC; Davis, SN; Schwartz, BS
      Alteplase activity

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    4. Watanabe, R; Wada, H; Miura, Y; Murata, Y; Watanabe, Y; Sakakura, M; Okugawa, Y; Nakasaki, T; Mori, Y; Nishikawa, M; Gabazza, EC; Shiku, H; Nobori, T
      Plasma levels of total plasminogen activator inhibitor-I (PAI-I) and tPA/PAI-1 complex in patients with disseminated intravascular coagulation and thrombotic thrombocytopenic purpura

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    5. Koh, SCL; Tham, KF; Razvi, K; Oei, PL; Lim, FK; Roy, AC; Prasad, RNV
      Hemostatic and fibrinolytic status in patients with ovarian cancer and benign ovarian cysts: Could D-dimer and antithrombin III levels be included asprognostic markers for survival outcome?

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    6. Sumii, T; Singhal, AB; Asahi, M; Shimizu-Sasamata, M; Suzuki, M; Miyata, K; Lo, EH
      Protective effects of pamiteplase, a modified t-PA, in a rat model of embolic stroke

      NEUROREPORT
    7. Olivotti, L; Spallarossa, P; Piana, A; Iannone, A; Rossettin, P; Ghigliotti, G; Armani, U; Barsotti, A; Brunelli, C
      Maximal endothelial tissue plasminogen activator release is not impaired in patients with acute coronary syndromes before heparin treatment

      BLOOD COAGULATION & FIBRINOLYSIS
    8. Stief, TW; Kretschmer, V; Kosche, B; Doss, MO; Renz, H
      Thrombin converts singlet oxygen (O-1(2))-oxidized fibrinogen into a soluble t-PA cofactor - A new method for preparing a stimulator for functional t-PA assays

      ANNALS OF HEMATOLOGY
    9. Huber, K
      Plasminogen activator inhibitor type-1 (part two): Role for failure of thrombolytic therapy. PAI-1 resistance as a potential benefit for new fibrinolytic agents

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    10. Aoki, S; Shimizu, N; Shimonishi, M; Kitagawa, M; Okumura, K; Tanigawara, Y
      Influence of sugar chain on fibrin affinity of recombinant t-PA

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    11. Gladstone, DJ; Black, SE
      Update on intravenous tissue plasminogen activator for acute stroke: from clinical trials to clinical practice

      CANADIAN MEDICAL ASSOCIATION JOURNAL
    12. Aoki, S; Kitagawa, M; Okumura, K
      Pharmacokinetic studies of Gln117 tissue-type plasminogen activator in rats

      JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    13. Magnusson, C; Hogklint, L; Libelius, R; Tagerud, S
      Expression of mRNA for plasminogen activators and protease nexin-1 in innervated and denervated mouse skeletal muscle

      JOURNAL OF NEUROSCIENCE RESEARCH
    14. Raaphorst, J; Groeneveld, ABJ; Bossink, AWJ; Hack, CE
      Early inhibition of activated fibrinolysis predicts microbial infection, shock and mortality in febrile medical patients

      THROMBOSIS AND HAEMOSTASIS
    15. Paramo, JA; Orbe, J; Fernandez, J
      Fibrinolysis/proteolysis balance in stable angina pectoris in relation to angiographic findings

      THROMBOSIS AND HAEMOSTASIS
    16. Hill, MD; Buchan, AM
      Methodology for the Canadian Activase For Stroke Effectiveness Study (CASES)

      CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
    17. Dominguez, M; Cacoub, P; de la Torre, IG; Piette, JC; Salazar-Paramo, M; Godeau, P; Angles-Cano, E
      Autoantibodies to receptor induced neoepitopes of fibrinolytic proteins inrheumatic and vascular diseases

      JOURNAL OF RHEUMATOLOGY
    18. Aoki, K; Aikawa, N; Sekine, K; Yamazaki, M; Mimura, T; Urano, T; Takada, A
      Elevation of plasma free PAI-1 levels as an integrated endothelial response to severe burns

      BURNS
    19. Petik, AV; Platonova, TN; Andrianov, SI; Pyaskovskaya, ON; Savchuk, AN; Lukinova, NI; Yakovlev, SA; Chekhun, VF
      Some indices of haemostasis during Lewis lung carcinoma growth

      EXPERIMENTAL ONCOLOGY
    20. Liang, JF; Park, YJ; Song, H; Li, YT; Yang, VCM
      ATTEMPTS: A heparin/protamine-based prodrug approach for delivery of thrombolytic drugs

      JOURNAL OF CONTROLLED RELEASE
    21. Gibson, CM; Marble, SJ
      Issues in the assessment of the safety and efficacy of tenecteplase (TNK-tPA)

      CLINICAL CARDIOLOGY
    22. Abou-Agag, LH; Tabengwa, EM; Tresnak, JA; Wheeler, CG; Taylor, KB; Booyse, FM
      Ethanol-induced increased surface-localized fibrinolytic activity in cultured human endothelial cells: Kinetic analysis

      ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
    23. Labinjoh, C; Newby, DE; Wilkinson, IB; Megson, IL; MacCallum, H; Melville, V; Boon, NA; Webb, DJ
      Effects of acute methionine loading and vitamin C on endogenous fibrinolysis, endothelium-dependent vasomotion and platelet aggregation

      CLINICAL SCIENCE
    24. Llevadot, J; Giugliano, RP; Antman, EM
      Bolus fibrinolytic therapy in acute myocardial infarction

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    25. Asakura, H; Ontachi, Y; Mizutani, T; Kato, M; Saito, M; Kumabashiri, I; Morishita, E; Yamazaki, M; Aoshima, K; Nakao, S
      An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation

      CRITICAL CARE MEDICINE
    26. Noguchi, T; Matsuyama, S; Akao, M; Hagiwara, H; Uno, S; Seki, T; Ariga, T
      Induction of hepatic tissue-type plasminogen activator and type 1 plasminogen activator-inhibitor gene expressions and appearance of their translation products in the bile following acute liver injury in rats

      THROMBOSIS RESEARCH
    27. Jansen, JWCM; van den Brink, H; Hoogenboom, PH
      Method to measure in vivo blood fibrinolytic activity with a I-125-fibrin coated aorta loop validated with agents which affect blood fibrinolytic activity

      THROMBOSIS RESEARCH
    28. Nowak-Gottl, U; Kotthoff, S; Hagemeyer, E; Junker, R; Kehl, HG; Vielhaber, H; Kececioglu, D
      Interaction of fibrinolysis and prothrombotic risk factors in neonates, infants and children with and without thromboembolism and underlying cardiac disease - A prospective study

      THROMBOSIS RESEARCH
    29. Oikawa, K; Kamimura, H; Watanabe, T; Miyamoto, I; Higuchi, S
      Pharmacokinetic properties of a novel tissue-type plasminogen activator pamiteplase after single intravenous administration to rats, dogs, and monkeys

      THROMBOSIS RESEARCH
    30. Reed, SD; Cramer, SC; Blough, DK; Meyer, K; Jarvik, JG
      Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals

      STROKE
    31. Koennecke, HC; Nohr, R; Leistner, S; Marx, P
      Intravenous tPA for ischemic stroke team performance over time, safety, and efficacy in a single-center, 2-year experience

      STROKE
    32. Tjarnstrom, J; Holmdahl, L; Falk, P; Falkenberg, M; Arnell, P; Risberg, B
      Effects of hyperbaric oxygen on expression of fibrinolytic factors of human endothelium in a simulated ischaemia/reperfusion situation

      SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
    33. Choi, KS; Fitzpatrick, SL; Filipenko, NR; Fogg, DK; Kassam, G; Magliocco, AM; Waisman, DM
      Regulation of plasmin-dependent fibrin clot lysis by annexin II heterotetramer

      JOURNAL OF BIOLOGICAL CHEMISTRY
    34. Landriscina, M; Soldi, R; Bagala, C; Micucci, I; Bellum, S; Tarantini, F; Prudovsky, I; Maciag, T
      S100A13 participates in the release of fibroblast growth factor 1 in response to heat shock in vitro

      JOURNAL OF BIOLOGICAL CHEMISTRY
    35. Costa, M; Medcalf, RL
      Ectopic expression of the cAMP-responsive element binding protein inhibitsphorbol ester-mediated induction of tissue-type plasminogen activator geneexpression

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    36. Armstrong, PW; Collen, D
      Fibrinolysis for acute myocardial infarction - Current status and new horizons for pharmacological reperfusion, Part 1

      CIRCULATION
    37. Nicholls, SC; Chandler, WL; Hoffer, EK
      Thrombolysis failure: A role for plasminogen activator inhibitor type 1 (PAI-1)

      BRITISH JOURNAL OF HAEMATOLOGY
    38. Wiebe, MG; Karandikar, A; Robson, GD; Trinci, APJ; Candia, JLF; Trappe, S; Wallis, G; Rinas, U; Derkx, PMF; Madrid, SM; Sisniega, H; Faus, I; Montijn, R; van den Hondel, CAMJJ; Punt, PJ
      Production of tissue plasminogen activator (t-PA) in Aspergillus niger

      BIOTECHNOLOGY AND BIOENGINEERING
    39. Dowd, JE; Kwok, KE; Piret, JM
      Glucose-based optimization of CHO-cell perfusion cultures

      BIOTECHNOLOGY AND BIOENGINEERING
    40. Werner, RG
      Improving natural principles with genetic engineering: TNK-tissue plasminogen activator

      ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    41. Sanchez, MC; Chiabrando, GA; Vides, MA
      Pregnancy zone protein-tissue-type plasminogen activator complexes bind tolow-density lipoprotein receptor-related protein (LRP)

      ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
    42. Vaughan, DE
      Angiotensin, fibrinolysis, and vascular homeostasis

      AMERICAN JOURNAL OF CARDIOLOGY
    43. Ross, AM; Gao, RL; Coyne, KS; Chen, JL; Yao, KB; Yang, YJ; Qin, XW; Qiao, SB; Yao, M
      A randomized trial confirming the efficacy of reduced dose recombinant tissue plasminogen activator in a Chinese myocardial infarction population anddemonstrating superiority to usual dose urokinase: The TUCC trial

      AMERICAN HEART JOURNAL
    44. Andronicos, NM; Baker, MS; Lackmann, M; Ranson, M
      Deconstructing the interaction of glu-plasminogen with its receptor alpha-enolase

      FIBRINOLYSIS & PROTEOLYSIS
    45. Prisco, D; Fedi, S; Brunelli, T; Chiarugi, L; Gianni, R; Santoro, E; Cappelletti, C; Pepe, G; Gensini, GF; Abbate, R
      Fibrinolytic parameters in young adults: the Floren-teen (Florence Teenager) Study

      FIBRINOLYSIS & PROTEOLYSIS
    46. Petersen, KR; Jorgensen, M; Vinberg, N; Gram, J; Skouby, SO; Tonnesen, KH; Jespersen, J
      Decreased synthesis of tissue plasminogen activator antigen in users of oral contraceptives

      FIBRINOLYSIS & PROTEOLYSIS
    47. Manhem, K; Dotevall, A; Wilhelmsen, L; Jern, S
      Preserved tissue-type plasminogen activator release and endothelium-dependent vasodilation in postmenopausal women with NIDDM

      JOURNAL OF DIABETES AND ITS COMPLICATIONS
    48. Semba, CP; Murphy, TP; Bakal, CW; Calis, KA; Matalon, TAS
      Thrombolytic therapy with use of alteplase (rt-PA) in peripheral arterial occlusive disease: Review of the clinical literature

      JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
    49. Gurewich, V
      Fibrinolysis: an unfinished agenda

      BLOOD COAGULATION & FIBRINOLYSIS
    50. Hunter, KA; Crosbie, LC; Weir, A; Miller, GJ; Dutta-Roy, AK
      A residential study comparing the effects of diets rich in stearic acid, oleic acid, and linoleic acid on fasting blood lipids, hemostatic variables and platelets in young healthy men

      JOURNAL OF NUTRITIONAL BIOCHEMISTRY
    51. Sherman, DL
      Exercise and endothelial function

      CORONARY ARTERY DISEASE
    52. Koenig, W; Ernst, E
      Exercise and thrombosis

      CORONARY ARTERY DISEASE
    53. Aoki, S; Shimizu, N; Koyama, J; Kato, Y; Kitagawa, M; Okumura, K; Tanigawara, Y
      Influence of N-terminal peptide and oligosaccharide on the clearance of t-PA

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    54. Folsom, AR
      Fibrinolytic factors and atherothrombotic events: epidemiological evidence

      ANNALS OF MEDICINE
    55. Engelstein, E; Margulies, J; Jeret, JS
      Lack of t-PA use for acute ischemic stroke in a community hospital: High incidence of exclusion criteria

      AMERICAN JOURNAL OF EMERGENCY MEDICINE
    56. Lottermoser, K; Hertfelder, HJ; Vetter, H; Dusing, R
      Renin-angiotensin-aldosterone system and fibrinolysis

      MEDIZINISCHE KLINIK
    57. Muneer, E; Bell, J; Doctor, VM
      Mechanism of enhancement by fucoidan and CNBr-fibrinogen digest of the activation of glu-plasminogen by tissue plasminogen activator

      EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
    58. Linenberger, ML; Kindelan, J; Bennett, RL; Reiner, AP; Cote, HCF
      Fibrinogen Bellingham: A gamma-chain R275C substitution and a beta-promoter polymorphism in a thrombotic member of an asymptomatic family

      AMERICAN JOURNAL OF HEMATOLOGY
    59. Nakasaki, T; Wada, H; Mori, Y; Okugawa, Y; Watanabe, R; Nishikawa, M; Gabazza, EC; Masuya, M; Kageyama, S; Kumeda, K; Kato, H; Shiku, H
      Decreased tissue factor and tissue-plasminogen activator antigen in relapsed acute promyelocytic leukemia

      AMERICAN JOURNAL OF HEMATOLOGY
    60. Leng, HMJ; Brouwers, E; Knockaert, I; Declerck, PJ
      Immunoassays for the quantitation of porcine PAI-1 antigen and activity inbiological fluid samples

      THROMBOSIS AND HAEMOSTASIS
    61. Sjogren, LS; Gan, LM; Doroudi, R; Jern, C; Jungersten, L; Jern, S
      Fluid shear stress increases the intra-cellular storage pool of tissue-type plasminogen activator in intact human conduit vessels

      THROMBOSIS AND HAEMOSTASIS
    62. Gunther, A; Mosavi, P; Ruppert, C; Heinemann, S; Temmesfeld, B; Velcovsky, HG; Morr, H; Grimminger, F; Walmrath, D; Seeger, W
      Enhanced tissue factor pathway activity and fibrin turnover in the alveolar compartment of patients with interstitial lung disease

      THROMBOSIS AND HAEMOSTASIS
    63. Camani, C; Gavin, O; Kruithof, EKO
      Cellular degradation of free and inhibitor-bound tissue-type plasminogen activator - Requirement for a co-receptor?

      THROMBOSIS AND HAEMOSTASIS
    64. Chandler, WL; Alessi, MC; Aillaud, MF; Vague, P; Juhan-Vague, I
      Formation, inhibition and clearance of plasmin in vivo

      HAEMOSTASIS
    65. Vivien, D; Buisson, A
      Serine protease inhibitors: Novel therapeutic targets for stroke?

      JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    66. Tabengwa, EM; Abou-Agag, LH; Benza, RL; Torres, JA; Aikens, ML; Booyse, FM
      Ethanol-induced up-regulation of candidate plasminogen receptor annexin IIin cultured human endothelial cells

      ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
    67. Yarzabal, A; Avilan, L; Hoelzl, K; de Munoz, M; Puig, J; Kansau, I
      A study of the interaction between Helicobacter pylori and components of the human fibrinolytic system

      BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
    68. Nagaoka, MR; Kouyoumdjian, M; Borges, DR
      The hepatic clearance of recombinant tissue-type plasminogen activator decreases after an inflammatory stimulus

      BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
    69. Katzan, IL; Furlan, AJ; Lloyd, LE; Frank, JI; Harper, DL; Hinchey, JA; Hammel, JP; Qu, A; Sila, CA
      Use of tissue-type plasminogen activator for acute ischemic stroke - The Cleveland area experience

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    70. Fukao, H; Matsuo, O
      Antithrombotic regulation in human endothelial cells by fibrinolytic factors

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    71. Ieko, M; Ichikawa, K; Atsumi, T; Takeuchi, R; Sawada, KI; Yasukouchi, T; Koike, T
      Effects of beta 2-glycoprotein I and monoclonal anticardiolipin antibodieson extrinsic fibrinolysis

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    72. Oikawa, K; Watanabe, T; Miyamoto, I; Higuchi, S
      Determination, pharmacokinetics and protein binding of a novel tissue-typeplasminogen activator, pamiteplase in human plasma

      XENOBIOTICA
    73. Hooper, WC; Lally, C; Austin, H; Renshaw, M; Dilley, A; Wenger, NK; Phillips, DJ; Whitsett, C; Rawlins, P; Evatt, BL
      The role of the t-PA I/D and PAI-1 4G/5G polymorphisms in African-Americanadults with a diagnosis of myocardial infarction or venous thromboembolism

      THROMBOSIS RESEARCH
    74. Prisco, D; Paniccia, R; Bandinelli, B
      Effect of temperature and incubation time on D-dimer serum levels in healthy subjects

      THROMBOSIS RESEARCH
    75. Huber, K
      Increase of efficacy of thrombolytic therapy in acute myocardial infarction by improvement of the characteristics of new fibrinolytic agents

      WIENER KLINISCHE WOCHENSCHRIFT
    76. Ruibal, A; Arias, JI; del Rio, MC; San Roman, JM; Lapena, G; Schneider, J; Tejerina, A
      The cytosolic hyaluronic acid level defines some clinical-biological properties of CD44v5-positive infiltrating ductal carcinomas of the breast

      MEDICINA CLINICA
    77. Fukao, H; Ueshima, S; Okada, K; Matsuo, O
      Binding of mutant tissue-type plasminogen activators to human endothelial cells and their extracellular matrix

      LIFE SCIENCES
    78. Bolliger-Stucki, B; Baillod, P; Mader, W; Furlan, M
      Biochemical properties of the fibrinogen component of a fibrin glue beforeand after severe dry heat treatment

      JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
    79. Goldfinger, LE; Jiang, LH; Hopkinson, SB; Stack, MS; Jones, JCR
      Spatial regulation and activity modulation of plasmin by high affinity binding to the G domain of the alpha(3) subunit of laminin-5

      JOURNAL OF BIOLOGICAL CHEMISTRY
    80. Rutanen, EM; Hurskainen, R; Finne, P; Nokalainen, K
      Induction of endometrial plasminogen activator-inhibitor 1: a possible mechanism contributing to the effect of intrauterine levonorgestrel in the treatment of menorrhagia

      FERTILITY AND STERILITY
    81. Costa, M; Shen, Y; Medcalf, RL
      Overexpression of a dominant negative CREB protein in HT-1080 cells selectively disrupts plasminogen activator inhibitor type 2 but not tissue-type plasminogen activator gene expression

      FEBS LETTERS
    82. Kruszynska, YT; Yu, JG; Olefsky, JM; Sobel, BE
      Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects

      DIABETES
    83. Chandler, WL; Jascur, ML; Henderson, PJ
      Measurement of different forms of tissue plasminogen activator in plasma

      CLINICAL CHEMISTRY
    84. Labinjoh, C; Newby, DE; Dawson, P; Johnston, NR; Ludlam, CA; Boon, NA; Webb, DJ
      Fibrinolytic actions of intra-arterial angiotensin II and bradykinin in vivo in man

      CARDIOVASCULAR RESEARCH
    85. Cugno, M; Dominguez, M; Cabibbe, M; Bisiani, G; Galli, M; Angles-Cano, E; Agostoni, A
      Antibodies to tissue-type plasminogen activator in plasma from patients with primary antiphospholipid syndrome

      BRITISH JOURNAL OF HAEMATOLOGY
    86. Kawasaki, T; Dewerchin, M; Lijnen, HR; Vermylen, J; Hoylaerts, MF
      Vascular release of plasminogen activator inhibitor-1 impairs fibrinolysisduring acute arterial thrombosis in mice

      BLOOD
    87. Fann, CH; Guirgis, F; Chen, G; Lao, MS; Piret, JM
      Limitations to the amplification and stability of human tissue-type plasminogen activator expression by Chinese hamster ovary cells

      BIOTECHNOLOGY AND BIOENGINEERING
    88. Yakovlev, S; Makogonenko, E; Kurochkina, N; Nieuwenhuizen, W; Ingham, K; Medved, L
      Conversion of fibrinogen to fibrin: Mechanism of exposure of tPA- and plasminogen-binding sites

      BIOCHEMISTRY
    89. Fitzpatrick, SL; Kassam, G; Choi, KS; Kang, HM; Fogg, DK; Waisman, DM
      Regulation of plasmin activity by annexin II tetramer

      BIOCHEMISTRY
    90. Verstraete, M
      Third-generation thrombolytic drugs

      AMERICAN JOURNAL OF MEDICINE
    91. Ioannidou-Papayannaki, E; Lefkos, N; Boudonas, G; Efthimiadis, A; Psirropoulos, D; Vogas, V; Papadopoulos, I; Klonizakis, I
      Alterations in the fibrinolytic system components during acute myocardial infarction

      ACTA CARDIOLOGICA
    92. Booth, NA
      Fibrinolysis and thrombosis

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    93. Holmberg, A; Westman, B; Bergqvist, D; Siegbahn, A
      Fibrinolysis in open abdominal aortic aneurysm surgery

      FIBRINOLYSIS & PROTEOLYSIS
    94. Newby, DE; Strachan, FE; Johnston, NR; Webb, DJ
      Endothelin-1 does not contribute to the release of tissue plasminogen activator in vivo in man

      FIBRINOLYSIS & PROTEOLYSIS
    95. Smith, BJ
      Thrombolysis in acute myocardial infarction: analysis of studies comparingaccelerated t-PA and streptokinase

      JOURNAL OF ACCIDENT & EMERGENCY MEDICINE
    96. Siu, YCA; Wong, TW; Lau, CC
      Candidates for thrombolytic treatment in acute ischaemic stroke - where are our patients in Hong Kong?

      JOURNAL OF ACCIDENT & EMERGENCY MEDICINE
    97. Tjarnstrom, J; Holmdahl, L; Arnell, P; Falkenberg, M; Risberg, B
      Treatment with hyperbaric oxygen affects endothelial cell fibrinolysis

      EUROPEAN JOURNAL OF SURGERY
    98. Rosnoblet, C; Vischer, UM; Gerard, RD; Irminger, JC; Halban, PA; Kruithof, EKO
      Storage of tissue-type plasminogen activator in Weibel-Palade bodies of human endothelial cells

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    99. Yamada, R; Ueno, S; Ishii, A; Yamada, S
      Idiopathic central serous chorioretinopathy: Promoting factors

      ANNALS OF OPHTHALMOLOGY & GLAUCOMA
    100. Kang, HM; Choi, KS; Kassam, G; Fitzpatrick, SL; Kwon, M; Waisman, DM
      Role of annexin II tetramer in plasminogen activation

      TRENDS IN CARDIOVASCULAR MEDICINE


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 07/08/20 alle ore 14:45:47